← Back to Search

Prescription Digital Therapeutic

Single arm for Schizophrenia

N/A
Waitlist Available
Research Sponsored by Click Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from week 3 to week 7 of the mobile agnew relationships measure
Awards & highlights
No Placebo-Only Group

Summary

This trial tests CT-155, a software-based treatment for adults with schizophrenia. The software offers activities and exercises to help manage symptoms.

Eligible Conditions
  • Schizophrenia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from week 3 to week 7 of the mobile agnew relationships measure
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from week 3 to week 7 of the mobile agnew relationships measure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility and acceptability with the study app as measured by Mobile App Rating Scale (MARS) at week 7
Secondary study objectives
Change in strength of digital working alliance from Week 3 to Week 7 as assessed by the Mobile Agnew Relationships Measure (mARM)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Single arm acceptability and feasibility of CT-155.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CT-155 smartphone app
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Click Therapeutics, Inc.Lead Sponsor
16 Previous Clinical Trials
2,989 Total Patients Enrolled
5 Trials studying Schizophrenia
807 Patients Enrolled for Schizophrenia
Shaheen Lakhan, MDPhD, FAANStudy ChairClick Therapeutics
4 Previous Clinical Trials
286 Total Patients Enrolled
1 Trials studying Schizophrenia
48 Patients Enrolled for Schizophrenia
~15 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top